- Home
- NKSH vs CATX Comparison
NKSH vs CATX Comparison
Compare NKSH & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NKSH | CATX |
|---|---|---|
| Founded | 1891 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 256.1M | 262.5M |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | NKSH | CATX |
|---|---|---|
| Price | $39.17 | $0.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $10.57 |
| AVG Volume (30 Days) | 19.3K | ★ 3.3M |
| Earning Date | 10-22-2026 | 11-17-2026 |
| Dividend Yield | ★ 3.83% | N/A |
| EPS Growth | ★ 100.81 | N/A |
| EPS | ★ 1.57 | N/A |
| Revenue | ★ $8,176,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.20 |
| P/E Ratio | $25.87 | ★ N/A |
| Revenue Growth | ★ 9.39 | N/A |
| 52 Week Low | $28.35 | $0.84 |
| 52 Week High | $45.99 | $6.16 |
Technical Indicators
Market Signals| Indicator | NKSH | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 37.36 | 20.68 |
| Support Level | $38.68 | N/A |
| Resistance Level | $40.00 | $2.40 |
| Average True Range (ATR) | 1.36 | 0.21 |
| MACD | -0.32 | -0.06 |
| Stochastic Oscillator | 9.72 | 4.72 |
Price Performance
Historical ComparisonAbout NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural loans, commercial real estate, construction loans for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary. The company earns its revenue from interest and fees on loans, non-interest income, and investments.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.